2024 Q1 Form 10-K Financial Statement

#000109181824000027 Filed on March 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $165.6K $232.3K
YoY Change -15.67% -46.49%
Operating Profit -$165.6K -$232.3K
YoY Change -15.67% -46.49%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.000K $12.00K
YoY Change 0.0% 0.0%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$165.6K -$232.3K
YoY Change -15.67% -46.49%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 231.1M shares 231.1M shares 197.2M shares
Diluted Shares Outstanding 234.8M shares 197.2M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $259.2K $108.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $259.2K $108.00
YoY Change 3623.42% -91.59%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $259.2K $108.00
Total Long-Term Assets $0.00 $0.00
Total Assets $259.2K $108.00
YoY Change 3623.42% -91.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.88K $9.900K
YoY Change 3695.25% -97.54%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $83.88K $9.900K
Total Long-Term Liabilities
Total Liabilities $83.88K $9.900K
YoY Change 3695.25% -97.54%
SHAREHOLDERS EQUITY
Retained Earnings -$1.032M -$866.0K
YoY Change 24.28% 36.66%
Common Stock $236.9K $231.1K
YoY Change 2.52% 164.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $175.3K -$9.792K
YoY Change
Total Liabilities & Shareholders Equity $259.2K $108.00
YoY Change 3623.42% -91.59%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$165.6K -$232.3K
YoY Change -15.67% -46.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$91.62K -$22.59K
YoY Change 190777.08% -43.94%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $350.7K $21.41K
YoY Change -46.31%
NET CHANGE
Cash From Operating Activities -$91.62K -$22.59K
Cash From Investing Activities
Cash From Financing Activities $350.7K $21.41K
Net Change In Cash $259.1K -$1.176K
YoY Change -539847.92% 182.69%
FREE CASH FLOW
Cash From Operating Activities -$91.62K -$22.59K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000894501
CY2023Q4 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
usd
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2022 grhi Common Stock Issued For Board Of Director And Consulting Services
CommonStockIssuedForBoardOfDirectorAndConsultingServices
usd
CY2022 grhi Common Stock Issued To Prepay Director For Payment Of Operating Expenses
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpenses
usd
CY2023 grhi Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023 us-gaap Interest Paid
InterestPaid
usd
CY2022 us-gaap Interest Paid
InterestPaid
usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023 us-gaap Revenues
Revenues
usd
CY2022 us-gaap Revenues
Revenues
usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023 us-gaap Gross Profit
GrossProfit
usd
CY2022 us-gaap Gross Profit
GrossProfit
usd
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-56304
CY2023 dei Entity Registrant Name
EntityRegistrantName
GOLD ROCK HOLDINGS, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0434297
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
2020 General Booth Blvd.
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Virginia Beach
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23454
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
25572691 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
231053636 shares
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1284 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
108 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1284 usd
CY2023Q4 us-gaap Assets
Assets
108 usd
CY2022Q4 us-gaap Assets
Assets
1284 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9900 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
372175 usd
CY2022Q4 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
31000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9900 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
403175 usd
CY2023Q4 us-gaap Liabilities
Liabilities
9900 usd
CY2022Q4 us-gaap Liabilities
Liabilities
403175 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-866037 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
231053636 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
231053636 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87482208 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87482208 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
231053 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
87482 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
625192 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
144353 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-633726 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9792 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-401891 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
108 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1284 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-232311 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-434182 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1000 usd
CY2023 grhi Common Stock Issued For Board Of Director And Consulting Services
CommonStockIssuedForBoardOfDirectorAndConsultingServices
172000 usd
CY2023 grhi Common Stock Issued To Prepay Director For Payment Of Operating Expenses
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpenses
29000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8725 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
362890 usd
CY2022 grhi Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
-30000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22586 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40292 usd
CY2023 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
21410 usd
CY2022 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
39876 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21410 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39876 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1176 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-416 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1284 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1700 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1284 usd
CY2023 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
170000 usd
CY2022 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
30000 usd
CY2023 grhi Consulting Fees Expenses
ConsultingFeesExpenses
12000 usd
CY2022 grhi Consulting Fees Expenses
ConsultingFeesExpenses
362500 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50311 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41682 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
232311 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
434182 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-232311 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-434182 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
197225847 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
197225847 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87461386 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87461386 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8585 usd
CY2022 grhi Capital Contributions Director
CapitalContributionsDirector
39876 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1000 usd
CY2023 grhi Common Stock Issued For Accounts Payable And Accrued Expenses
CommonStockIssuedForAccountsPayableAndAccruedExpenses
402000 usd
CY2023 grhi Common Stock Issued To Prepay Director For Payment Of Operating Expense
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpense
29000 usd
CY2023 grhi Common Stock Issued For Board Of Director Consulting Services
CommonStockIssuedForBoardOfDirectorConsultingServices
172000 usd
CY2023 grhi Capital Contributions Director
CapitalContributionsDirector
21410 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-232311 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9792 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_z4FfBd2vS5s5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_86F_zFrZ7AIE5PF5">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-866037 usd
CY2023Q4 grhi Working Capital
WorkingCapital
9792 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
231053636 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
231053636 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87482208 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87482208 shares
CY2023 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
40952381 shares
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
172000 usd
CY2023 grhi Common Stock Issued For Consulting And Director Compensation Shares
CommonStockIssuedForConsultingAndDirectorCompensationShares
6904761 shares
CY2023 grhi Common Stock Issued For Consulting And Director Compensation
CommonStockIssuedForConsultingAndDirectorCompensation
29000 usd
CY2022 grhi Common Stock Issued For Professional Services Shares
CommonStockIssuedForProfessionalServicesShares
100000 shares
CY2022 grhi Common Stock Issued For Professional Services
CommonStockIssuedForProfessionalServices
1000 usd
CY2023 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
50410 usd
CY2022 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
39876 usd
CY2023 grhi Common Stock Issued To Prepay Director For Payment Of Operating Expenses
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpenses
29000 usd
CY2023 grhi Stock Issuance To Reimburse
StockIssuanceToReimburse
0.0042
CY2023 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
21410 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
39876 usd
CY2023 grhi Agreement Monthly Charges
AgreementMonthlyCharges
1000 usd
CY2023 us-gaap Other Expenses
OtherExpenses
12000 usd
CY2022 us-gaap Other Expenses
OtherExpenses
12000 usd
CY2023Q4 grhi Accounts Payable
AccountsPayable
9000 usd
CY2022Q4 grhi Accounts Payable
AccountsPayable
21000 usd
CY2023 us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
The Company had a 5 year compensation agreement with its Board Chairman beginning January 1, 2022 and ending on December 31, 2026. Compensation was an annual fee of $30,000, due in the following month of January.
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
30000 usd
CY2022Q4 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
31000 usd
CY2028Q4 grhi Agreement Amount Payable
AgreementAmountPayable
95000 usd
CY2023Q1 grhi Agreement Amount Payable
AgreementAmountPayable
75000 usd
CY2023 grhi Board Of Director Compensation
BoardOfDirectorCompensation
170000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares

Files In Submission

Name View Source Status
0001091818-24-000027-index-headers.html Edgar Link pending
0001091818-24-000027-index.html Edgar Link pending
0001091818-24-000027.txt Edgar Link pending
0001091818-24-000027-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
grhi-20231231.xsd Edgar Link pending
grhi12312310k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
grhi-20231231_cal.xml Edgar Link unprocessable
grhi-20231231_def.xml Edgar Link unprocessable
grhi-20231231_lab.xml Edgar Link unprocessable
grhi-20231231_pre.xml Edgar Link unprocessable
grhi12312310k_htm.xml Edgar Link completed